A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.

一种新型血清生物标志物五重奏与前列腺癌患者的标准临床参数相结合，通过预测生化复发和不良病理，显示出额外的预后价值